medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2014, Number 609

<< Back Next >>

Rev Med Cos Cen 2014; 71 (609)

Úlcera péptica

Camacho MJE

Language: Spanish
References: 15
Page: 129-134
PDF size: 351.61 Kb.


ABSTRACT

Incidence of peptic ulcer disease has declined over the past 100 years; however the recent rise in life expectancy in has managed to maintain a constant prevalence of this disease. During the past 3 decades in the US, the rise in diagnoses made in advanced ages has contributed to a larger number of hospital admissions due to complications of peptic ulcer disease. These tendencies reflect the advancements made in the eradication therapy for Helicobacter pylori and therapy directed towards prevention of peptic ulcer disease with chronic use of NSAID’s.


REFERENCES

  1. Cheung F, Lau J. Management of MassivePepticUlcerBleeding. GastroeneterolClin N Am 38 (2009) 231-243.

  2. Cutler M, Goldstein J, Manuel D. Decreasing prevalence combined with increasing eradication of Helicobacter pylori infection in the United States has not resulted in fewer hospital admissions for peptic ulcer related complications. Aliment PhamacolTher (2007) 25, 1423- 1427.

  3. Delegge M, Garrow D. Risk Factors for Gastrointestinal ulcer disease in the US population. Dig Dis Sci (2010) 55, 66-72.

  4. Gibson J, Odze R. Pathology of Diseases that cause Upper Gastrointestinal Tract Bleeding. Gastrointest Endoscopy Clin N Am 21 (2011) 583-596.

  5. Grigorios L Howden C. The Role of Proton Pump Inhibotors in the Management of Upper Gastrointestinal Bleeding. GastroeneterolClin N Am 38 (2009) 199-213.

  6. Jensen D, Kovacs T. Endoscopic Therapy for Severe Ulcer Bleeding. Gastrointest Endoscopy Clin N Am 21 (2011) 681-691.

  7. Kuipers E, Kusters J, van Vliet A. Pathogenesis of Helicobacter pylori infection. Clinical Microbiology Reviews (2006) 19, 449-490.

  8. Kuipers E, Meijer G, Post P. Declining incidence of pepetic ulcer but not of its complications: a nationwide study in the Netherlands. Aliment PharmacolTher (2006) 23, 1587-1593.

  9. Leong R. Differences in Peptic Ulcer between the East and the West. GastroenterolClin N Am 38 (2009) 363-379. 134 REVISTA MEDICA DE COSTA RICA Y CENTROAMERICA

  10. Ma T, Sung J, Tsoi K, et al. Causes of mortality in patients with peptic ulcer bleeding: a prospective cohort study of 10 428 cases. GastroeneterolClin N Am 38 (2010) 84-89.

  11. McColl K. Helicobacter pylori- Negative Nonsteroidal Anti- Inflammatory Drug-Negative Ulcer. GastroenterolClin N Am 38 (2009) 353-361.

  12. Najm W. Peptic Ulcer Disease. Primary Care Clin Office Part 38 (2011). 383-394.

  13. Napolitano L. Refractory Peptic Ulcer Disease. GastroeneterolClin N Am 38 (2009) 267-288.

  14. Peura D, Wang A. The Prevalence and Incidence of Helicobacter pylori-associated Peptic Ulcer Disease and Upper Gastrointestinal Tract Bleeding throughout the World. Gastrointest Endoscopy Clin N Am 21 (2011) 613-635.

  15. Sung J. Current Management of pepetic ulcer bleeding. Nat Clin Gastroeneterol Hepatol (2006)




2020     |     www.medigraphic.com